GEMMA Biotherapeutics lands $34m seed

Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital led the round with participation from Savanne Life Sciences.

23 December 2024•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.